Literature DB >> 27528956

Non-typhoidal salmonella (NTS) bacteraemia in Malawian adults: a severe, recrudescent, HIV-associated illness.

Melita A Gordon1, Hastings T Banda1, Macpherson Gondwe1, Stephen B Gordon2, Amanda L Walsh2, Amos Phiri2, Charles F Gilks1, C Anthony Hart3, Malcolm E Molyneux4.   

Abstract

Non-typhoidal salmonella (NTS) bacteraemia is a common, recurrent illness in HIV-infected African adults. We aimed to describe the presentation and outcome of NTS bacteraemia, the pattern of recurrence, and to determine whether recurrence results from re-infection or recrudescence. 100 consecutive adult inpatients with NTS bacteraemia in Blantyre, Malawi were treated with chloramphenicol (500mg qid for 14 days). Survivors were prospectively followed to detect bacteraemic recurrence. Index and recurrent isolates were typed by antibiogram, pulsed field gel electrophoresis and plasmid analysis to distinguish recrudescence from re-infection. Inpatient mortality was 47%, and 1-year mortality was 77%. 77/78 cases were HIV positive. Anaemia was associated with inpatient death, and several features of AIDS were associated with poor outpatient survival. Among survivors, 43% (19/44) had a first recurrence of NTS bacteraemia at 23-186 days. Among these, 26% (5/19) developed multiple recurrences up to 245 days. No recurrence was seen after 245 days, despite follow-up for up to 609 days (median 214). Suppurative infections were not found at presentation, and were only seen twice at recurrence. Index and recurrent paired isolates were identical by phenotyping and genotyping, consistent with recrudescence, rather than re-infection. NTS bacteraemia has a high mortality (47%) and recurrence rate (43%) in HIV-infected African adults. Recurrence is caused by recrudescence rather than re-infection. Since focal infections were rarely found, recrudescence may often be a consequence of intracellular tissue sequestration. There is an urgent need for improved primary treatment and secondary prophylaxis in Africa.

Entities:  

Year:  2003        PMID: 27528956      PMCID: PMC3345431          DOI: 10.4314/mmj.v15i2.10776

Source DB:  PubMed          Journal:  Malawi Med J        ISSN: 1995-7262            Impact factor:   0.875


  22 in total

Review 1.  Infections in AIDS.

Authors:  C A Hart; N J Beeching; B I Duerden
Journal:  J Med Microbiol       Date:  2000-11       Impact factor: 2.472

2.  Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients.

Authors:  J L Casado; S Valdezate; C Calderon; E Navas; B Frutos; A Guerrero; J Martinez-Beltran
Journal:  J Infect Dis       Date:  1999-06       Impact factor: 5.226

Review 3.  Infectious endocarditis due to non-typhi Salmonella in patients infected with human immunodeficiency virus: report of two cases and review.

Authors:  M L Fernández Guerrero; R Torres Perea; J Gómez Rodrigo; A Núñez García; J J Jusdado; J M Ramos Rincón
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  Non-typhoidal Salmonella bacteraemia: clinical features and risk factors.

Authors:  V Thamlikitkul; C Dhiraputra; T Paisarnsinsup; C Chareandee
Journal:  Trop Med Int Health       Date:  1996-08       Impact factor: 2.622

Review 6.  Nontyphoidal salmonella intracranial infections in HIV-infected patients.

Authors:  L Aliaga; J D Mediavilla; A López de la Osa; M López-Gómez; M de Cueto; C Miranda
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

7.  Mechanism of interaction of Salmonella and Schistosoma species.

Authors:  R F Melhem; P T LoVerde
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

8.  Salmonella bacteremia associated with the acquired immunodeficiency syndrome (AIDS).

Authors:  R B Nadelman; U Mathur-Wagh; S R Yancovitz; D Mildvan
Journal:  Arch Intern Med       Date:  1985-11

9.  Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages.

Authors:  N A Buchmeier; F Heffron
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

10.  Salmonella pyomyositis in patients with the human immunodeficiency virus.

Authors:  F Medina; M Fuentes; L J Jara; L Barile; J M Miranda; A Fraga
Journal:  Br J Rheumatol       Date:  1995-06
View more
  2 in total

1.  Bacteraemia in Malawian neonates and young infants 2002-2007: a retrospective audit.

Authors:  Amanda Gwee; Benjamin Coghlan; Dean Everett; Newton Chagoma; Amos Phiri; Lorna Wilson; Elizabeth Molyneux
Journal:  BMJ Open       Date:  2012-05-15       Impact factor: 2.692

2.  Invasive non-typhoidal Salmonella infections in sub-Saharan Africa: a systematic review on antimicrobial resistance and treatment.

Authors:  Bieke Tack; Jolien Vanaenrode; Jan Y Verbakel; Jaan Toelen; Jan Jacobs
Journal:  BMC Med       Date:  2020-07-17       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.